Ritlecitinib - Pfizer
At a glance
- Drug Originator Pfizer
- Drug Class Amines; Anti-inflammatories; Antihyperglycaemics; Antirheumatics; Antiulcers; Heterocyclic bicyclo compounds; Ketones; Piperidines; Pyrimidines; Pyrroles; Skin disorder therapies; Small molecules
- Mechanism of Action Emt protein-tyrosine kinase inhibitors; Janus kinase 3 inhibitors
- USA Patent Applicants PFIZER
- USA Patents 4
- NDAs 1
- International Patents 85
Table of Contents
Disclaimer